分析員
主要指數



重點要聞
行業更新 | 中國醫療保健
恒生醫療保健指數在10月1日至15日期間下跌10.6%,表現顯著落後於恒指,主要受獲利回吐影響。 此前數週表現優異的英矽智能(Insilico)、晶泰科技(XtalPi)、康方生物(Akeso)及藥明生物(WuXi Bio),成為主要落後股份。 中國生物製藥企業將交出歷來最強勁的歐洲腫瘤學學會(ESMO)大會成績,共有29項研究獲選為重磅研究摘要。 隨著市場焦點從業務拓展轉向發布穩健的三期臨床數據,中國的創新實力應會繼續為該板塊的正面展望提供支持。 維持「與大市一致」評級。
重點要聞
行業更新 | 中國醫療保健
恒生醫療保健指數在10月1日至15日期間下跌10.6%,表現顯著落後於恒指,主要受獲利回吐影響。 此前數週表現優異的英矽智能(Insilico)、晶泰科技(XtalPi)、康方生物(Akeso)及藥明生物(WuXi Bio),成為主要落後股份。 中國生物製藥企業將交出歷來最強勁的歐洲腫瘤學學會(ESMO)大會成績,共有29項研究獲選為重磅研究摘要。 隨著市場焦點從業務拓展轉向發布穩健的三期臨床數據,中國的創新實力應會繼續為該板塊的正面展望提供支持。 維持「與大市一致」評級。
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.






